LONDON--(BUSINESS WIRE)--Technavio’s latest report on the global angina pectoris drugs market provides an analysis on the most important trends expected to impact the market outlook from 2017-2021.

LONDON, Feb. 21, 2018 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/5291766 The global angina pectoris drugs market is expected to be ...

LONDON, Oct. 3, 2017 /PRNewswire/ -- According to Stratistics MRC, the Global Angina Pectoris Drugs Market is accounted for $8501.3 million in 2016 and expected to grow at a CAGR of 6.7% to reach ...

DUBLIN--(BUSINESS WIRE)--The "Angina Pectoris: Global Drug Forecast and Market Analysis to 2028" report has been added to ResearchAndMarkets.com's offering. This report focuses on the following forms ...

The display and use of drug information on this site is subject to express terms of use. By continuing to view the drug information, you agree to abide by such terms ...

A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels -- thereby reducing the risk of heart attack or ...

The goals of treatment are to decrease the frequency of angina, increase longevity, and improve patients' QOL. Management of risk factors is an essential component of this therapy. Also important is ...

Individuals with undetected stable angina pectoris (SAP) as a consequence of undiagnosed coronary artery disease are at high risk of poor quality of life and a premature fatal event (for example, ...